A prognostic scoring system using inflammatory response biomarkers in oral cavity squamous cell carcinoma patients who underwent surgery-based treatment

Acta Otolaryngol. 2018 Apr;138(4):422-427. doi: 10.1080/00016489.2017.1404640. Epub 2017 Nov 23.

Abstract

Background: The aim of this study was to evaluate the effectiveness of a scoring system based on the lymphocyte-to-monocyte ratio, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio for predicting disease-specific survival of oral cancer patients treated by surgery.

Methods: From January 2007 to December 2016, we retrospectively analyzed data from 69 oral cancer patients who received surgery.

Results: Lymphocyte-to-monocyte ratio was significantly associated with T classification, N classification, and pathologic stage. Neutrophil-to-lymphocyte ratio was significantly associated with T classification and pathologic stage. Platelet-to-lymphocyte ratio was significantly associated with N classification and pathologic stage. In multivariate analysis, only a higher score on this scoring system was significantly associated with poorer disease-specific survival.

Conclusions: We found that the prognostic score system based on these three values was significantly associated with disease-specific survival of oral cancer patients who received surgery, indicating that the prognostic scoring system was effective in indirectly predicting systemic inflammatory response.

Keywords: Inflammatory response biomarker; oral cavity cancer; prognostic factor.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers
  • Carcinoma, Squamous Cell / immunology*
  • Carcinoma, Squamous Cell / mortality
  • Carcinoma, Squamous Cell / surgery
  • Female
  • Humans
  • Lymphocyte Count
  • Male
  • Middle Aged
  • Mouth Neoplasms / immunology*
  • Mouth Neoplasms / mortality
  • Mouth Neoplasms / surgery
  • Republic of Korea / epidemiology
  • Retrospective Studies

Substances

  • Biomarkers